Michael Sassano
Chief Executive Officer at Somaí Pharmaceuticals Ltd.
Profile
Michael Sassano has founded SOMAÍ Pharmaceuticals Ltd.
in 2019 and currently holds the position of Chairman & Chief Executive Officer.
Michael Sassano active positions
| Companies | Position | Start |
|---|---|---|
Somaí Pharmaceuticals Ltd.
 Somaí Pharmaceuticals Ltd. BiotechnologyHealth Technology SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019. | Chief Executive Officer | 2019-02-18 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Somaí Pharmaceuticals Ltd.
Somaí Pharmaceuticals Ltd. BiotechnologyHealth Technology SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- Michael Sassano
